Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Elisa Zucchetti"'
Autor:
Jari Intra, Alice Biffi, Francesca Basta, Cristina Delfini, Nicoletta Novati, Elisa Zucchetti, Fabrizio Luppi, Marco Casati
Publikováno v:
International Journal of Translational Medicine, Vol 4, Iss 2, Pp 381-386 (2024)
Hypersensitivity pneumonitis (HP) represents the third common interstitial lung disease caused by an exaggerated immune response following the inhalation of organic and/or chemical environmental antigens. The aim of this study was to determine the cu
Externí odkaz:
https://doaj.org/article/b346b750fbaf49c6b38a94b0fc82f726
Autor:
Jennifer M. Logue, Elisa Zucchetti, Christina A. Bachmeier, Gabriel S. Krivenko, Victoria Larson, Daniel Ninh, Giovanni Grillo, Biwei Cao, Jongphil Kim, Julio C. Chavez, Aliyah Baluch, Farhad Khimani, Aleksandr Lazaryan, Taiga Nishihori, Hien D. Liu, Javier Pinilla-Ibarz, Bijal D. Shah, Rawan Faramand, Anna E. Coghill, Marco L. Davila, Bhagirathbhai R. Dholaria, Michael D. Jain, Frederick L. Locke
Publikováno v:
Haematologica, Vol 106, Iss 4 (2020)
CD19 CAR T-cell therapy with axicabtagene ciloleucel (axi-cel) for relapsed or refractory (R/R) large B cell lymphoma (LBCL) may lead to durable remissions, however, prolonged cytopenias and infections may occur. In this single center retrospective s
Externí odkaz:
https://doaj.org/article/9b49d260a7484ec48b00e7dc0cef6f14
Autor:
Rawan Faramand, Aliyah Baluch, Julio C. Chavez, Anna E. Coghill, Gabriel S Krivenko, Marco L. Davila, Daniel Ninh, Christina A Bachmeier, Bijal D. Shah, Javier Pinilla-Ibarz, Bhagirathbhai Dholaria, Victoria Larson, Giovanni Grillo, Hien D. Liu, Aleksandr Lazaryan, Jongphil Kim, Elisa Zucchetti, Biwei Cao, Farhad Khimani, Taiga Nishihori, Frederick L. Locke, Jennifer M. Logue, Michael D. Jain
Publikováno v:
Haematologica
CD19 chimeric antigen receptor T (CAR T)-cell therapy with axicabtagene ciloleucel (axi-cel) for relapsed or refractory (R/R) large B-cell lymphoma (LBCL) may lead to durable remissions, however, prolonged cytopenias and infections may occur. In this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e52ac9604f7ca1353160a5ca109fc740
https://pubmed.ncbi.nlm.nih.gov/32327504
https://pubmed.ncbi.nlm.nih.gov/32327504
Autor:
Maria Grazia Pipitone, Daniela Lumia, Irene Cuppari, Silvano Rossini, Sonia Lo Po, Elisabetta Volpato, Giuliana Lando, Giorgia Cornacchini, Sara Labate, Roberto Crocchiolo, Giovanni Grillo, Lara Crucitti, Elisa Zucchetti, Elisabetta Sommaruga, Maria Teresa Pugliano
Publikováno v:
Current research in translational medicine. 69(2)
Purpose of the Study The detection of patients' anti-HLA antibodies before allogeneic hematopoietic stem cell transplantation (HSCT) may affect post-transplant outcome, due to a potential detrimental impact on engraftment or toxicity-related issues.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ea8bee13fd62350824827be9c3d7ca8
https://pubmed.ncbi.nlm.nih.gov/33765638
https://pubmed.ncbi.nlm.nih.gov/33765638
Autor:
Maria Teresa Pugliano, Roberto Crocchiolo, Irene Cuppari, Arianna Coviello, Giuliana Lando, Silvano Rossini, Giorgia Cornacchini, Elisa Zucchetti, Giovanni Grillo, Elisabetta Volpato
Publikováno v:
Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis. 59(4)
Introduction the identification of a suitable donor in an appropriate timing represents a crucial step in the preparation of allogeneic stem cell transplantation (HSCT). At our Institution, for patients lacking an HLA-identical sibling, a haploidenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5be5559b4e46b86c92b5c6bf10d902b
https://pubmed.ncbi.nlm.nih.gov/32276862
https://pubmed.ncbi.nlm.nih.gov/32276862
Autor:
Rosa Greco, Giovanni Grillo, Elisa Diral, Marta Riva, Roberto Cairoli, Silvio Veronese, Michele Nichelatti, Valentina Mancini, Elisa Zucchetti, Lorenzo Rizzo, Giambattista Bertani
Publikováno v:
Blood. 136:20-21
Background: The treatment for relapsed or refractory acute myeloid leukemia (R/R AML) has minimal chances and a low impact on improving survival. One of the most important goal is to treat unfit patients who are often intolerant to intensive chemothe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e77c4bdf2f9ce7163edbf6025367461
https://doi.org/10.1182/blood-2020-141987
https://doi.org/10.1182/blood-2020-141987
A 53-years old man with FLT3-ITD-mutant Acute Myeloid Leukemia relapsed ten months after hemopoietic allogeneic stem cell transplant as multiple cutaneous Myeloid Sarcomas. Molecular testing was performed on the core-needle biopsy of the lesion and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1299::86987c5f2df19c557002fe9101bf6d90
https://hdl.handle.net/10281/404336
https://hdl.handle.net/10281/404336
Autor:
Antonio M. Risitano, Salvatore Leotta, Adriana Vacca, Francesco Zallio, Fabio Giglio, Katia Perruccio, Stefano Mancini, Matteo Parma, Federica Sorà, Francesca Bonifazi, Alessandro Busca, Giuseppe Irrera, Elisa Diral, Anna Candoni, Anna Amelia Colombo, William Arcese, Anna Paola Iori, Agostino Cortelezzi, Riccardo Saccardi, Mariarosa Sessa, Roberto Sorasio, Attilio Olivieri, Enrico Orciuolo, Stefano Tringali, Giovanni Grillo, Alessandro Rambaldi, Andrea Velardi, Fabio Ciceri, Jacopo Olivieri, Elena Oldani, Francesco Albano, Benedetto Bruno, Elisa Zucchetti, Federico Lussana, Renato Fanin, Alessandra Picardi, Simona Sica, Sonia Mammoliti, Robin Foà, Cristina Tecchio, Paola Bresciani, Davide Lazzarotto, Paolo Bernasconi, Angelo Michele Carella, Michele Malagola, Stella Santarone, Alida Dominietto
We performed a nationwide registry-based analysis to describe the clinical outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who underwent an allogeneic hematopoietic stem cell transplantation (HSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82005d30d0e80421ee48c8d5c9831799
http://hdl.handle.net/11562/1018738
http://hdl.handle.net/11562/1018738
Autor:
Paola Marenco, Barbara Scarpati, Giovanni Grillo, Roberto Cairoli, Ursula Ferri, Silvano Rossini, Barbara Forno, Giuliana Lando, Clara Cesana, Elisa Zucchetti, Luca Santoleri, Giambattista Bertani
Publikováno v:
Transfusion. 56:505-510
BACKGROUND Extracorporeal photopheresis (ECP) is a recognized second-line treatment for steroid-refractory chronic graft-versus-host disease (cGVHD). Treatment course is usually long, expensive, and demanding for patients, so predictors for response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70c3323db76ef22a81d9deefcf304c83
https://doi.org/10.1111/trf.13369
https://doi.org/10.1111/trf.13369
Autor:
Elisabetta Volpato, Elisa Zucchetti, Roberto Cairoli, Mariateresa Pugliano, Tiziana Lamacchia, Laura Pezzetti, Giovanni Grillo, Liliana Intropido, Giambattista Bertani
Publikováno v:
Blood. 134:5633-5633
BACKGROUND Plerixafor (PLX) blocks the binding of stromal cell-derived factor to CXCR4, resulting in hematopoietic stem cell (HSC) release from the bone marrow. It has been successfully used as a mobilizing agent in poor mobilizers (PM). The best str
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f87b3e548d4823441d2d74d52dc60aeb
https://doi.org/10.1182/blood-2019-125055
https://doi.org/10.1182/blood-2019-125055